Role of FGF10 on tumorigenesis by MS-K

Genes to Cells

Volumn 19, Issue 2, 2014, Pages 112-125

  Sugimoto, Kenkichi ^a   Yoshida, Suzuka ^a   Mashio, Yuka ^a   Toyota, Naoka ^a   Xing, Yanjiang ^a   Xu, Henan ^a   Fujita, Yuki ^a   Huang, Zhijun ^b   Touma, Maki ^a   Wu, Qiong ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b HARBIN INSTITUTE OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR RECEPTOR 1; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN MS K; CLONE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE SILENCING; HUMAN; INOCULATION; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NONHUMAN; PARACRINE SIGNALING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR GROWTH; VASCULAR NECROSIS;

MURINAE;

ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; FIBROBLAST GROWTH FACTOR 10; GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84892970588     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/gtc.12118     Document Type: Article

References (38)

1. Ando, K., Hunter, N. & Peters, L.J. (1979) Immunologically nonspecific enhancement of artificial lung metastasis in tumor-bearing mice. Cancer Immunol. Immunother. 6, 151-156.
2. Andres, G., Leali, D., Mitola, S., Coltrini, D., Camozzi, M., Corsini, M., Belleri, M., Hirsch, E., Schwendener, R.A., Christofori, G., Alcami, A. & Presta, M. (2009) A pro-inflammatory signature mediates FGF2-induced angiogenesis. J. Cell Mol. Med. 13, 2083-2108.
3. Asaki, T., Konishi, M., Miyake, A., Kato, S., Tomizawa, M. & Itoh, N. (2004) Roles of fibroblast growth factor 10 (Fgf10) in adipogenesis in vivo. Mol. Cell. Endocrinol. 218, 119-128.
4. Beer, H.D., Florence, C., Dammeier, J., McGuire, L., Werner, S. & Duan, D.R. (1997) Mouse fibroblast growth factor 10: cDNA cloning, protein characterization, and regulation of mRNA expression. Oncogene 15, 2211-2218.
5. Chan, S.S., Li, H.J., Hsueh, Y.C., Lee, D.S., Chen, J.H., Hwang, S.M., Chen, C.Y., Shih, E. & Hsieh, P.C. (2010) Fibroblast growth factor-10 promotes cardiomyocyte differentiation from embryonic and induced pluripotent stem cells. PLoS ONE 5, e14414.
6. Chen, L., Endler, A., Uchida, K., Horiguchi, S., Morizane, Y., Iijima, O., Toi, M. & Shibasaki, F. (2010) Int6/eIF3e silencing promotes functional blood vessel outgrowth and enhances wound healing by upregulating hypoxia-induced factor 2alpha expression. Circulation 122, 910-919.
7. Claesson-Welsh, L. (2012) Blood vessels as targets in tumor therapy. Ups. J. Med. Sci. 117, 178-186.
8. Claffey, K.P., Wilkison, W.O. & Spiegelman, B.M. (1992) Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J. Biol. Chem. 267, 16317-16322.
9. Das, B., Yeger, H., Tsuchida, R., Torkin, R., Gee, M.F., Thorner, P.S., Shibuya, M., Malkin, D. & Baruchel, S. (2005) A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma. Cancer Res. 65, 7267-7275.
10. Ferrara, N. (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 25, 581-611.
11. Frontini, M.J., Nong, Z., Gros, R., Drangova, M., O'Neil, C., Rahman, M.N., Akawi, O., Yin, H., Ellis, C.G. & Pickering, J.G. (2011) Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smooth muscle cells. Nat. Biotechnol. 29, 421-427.
12. Haigh, J.J. (2008) Role of VEGF in organogenesis. Organogenesis 4, 247-256.
13. Itoh, N. & Ornitz, D.M. (2008) Functional evolutionary history of the mouse Fgf gene family. Dev. Dyn. 237, 18-27.
14. Kelly, B.D., Hackett, S.F., Hirota, K., Oshima, Y., Cai, Z., Berg-Dixon, S., Rowan, A., Yan, Z., Campochiaro, P.A. & Semenza, G.L. (2003) Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ. Res. 93, 1074-1081.
15. Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S. & Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841-844.
16. Koblizek, T.I., Weiss, C., Yancopoulos, G.D., Deutsch, U. & Risau, W. (1998) Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr. Biol. 8, 529-532.
17. Larrieu-Lahargue, F., Welm, A.L., Bouchecareilh, M., Alitalo, K., Li, D.Y., Bikfalvi, A. & Auguste, P. (2012) Blocking Fibroblast Growth Factor receptor signaling inhibits tumor growth, lymphangiogenesis, and metastasis. PLoS ONE 7, e39540.
18. Liu, W., Shen, S.M., Zhao, X.Y. & Chen, G.Q. (2012) Targeted genes and interacting proteins of hypoxia inducible factor-1. Int. J. Biochem. Mol. Biol. 3, 165-178.
19. Luo, Y., Lu, W., Mohamedali, K.A., Jang, J.H., Jones, R.B., Gabriel, J.L., Kan, M. & McKeehan, W.L. (1998) The glycine box: a determinant of specificity for fibroblast growth factor. Biochemistry 37, 16506-16515.
20. Matsumoto, G., Kushibiki, T., Kinoshita, Y., Lee, U., Omi, Y., Kubota, E. & Tabata, Y. (2006) Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma. Cancer Sci. 97, 313-321.
21. Min, H., Danilenko, D.M., Scully, S.A., Bolon, B., Ring, B.D., Tarpley, J.E., DeRose, M. & Simonet, W.S. (1998) Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless. Genes Dev. 12, 3156-3161.
22. Murakami, M., Nguyen, L.T., Hatanaka, K., Schachterle, W., Chen, P.Y., Zhuang, Z.W., Black, B.L. & Simons, M. (2011) FGF-dependent regulation of VEGF receptor 2 expression in mice. J. Clin. Invest. 121, 2668-2678.
23. Ohuchi, H., Hori, Y., Yamasaki, M., Harada, H., Sekine, K., Kato, S. & Itoh, N. (2000) FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem. Biophys. Res. Commun. 277, 643-649.
24. Peters, K., Werner, S., Liao, X., Wert, S., Whitsett, J. & Williams, L. (1994) Targeted expression of a dominant negative FGF receptor blocks branching morphogenesis and epithelial differentiation of the mouse lung. EMBO J. 13, 3296-3301.
25. Prewett, M., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, K., Overholser, J., Hooper, A., Pytowski, B., Witte, L., Bohlen, P. & Hicklin, D.J. (1999) Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res. 59, 5209-5218.
26. Sakaue, H., Konishi, M., Ogawa, W., Asaki, T., Mori, T., Yamasaki, M., Takata, M., Ueno, H., Kato, S., Kasuga, M. & Itoh, N. (2002) Requirement of fibroblast growth factor 10 in development of white adipose tissue. Genes Dev. 16, 908-912.
27. Sekine, K., Ohuchi, H., Fujiwara, M., Yamasaki, M., Yoshizawa, T., Sato, T., Yagishita, N., Matsui, D., Koga, Y., Itoh, N. & Kato, S. (1999) Fgf10 is essential for limb and lung formation. Nat. Genet. 21, 138-141.
28. Shibata, M.A., Morimoto, J., Shibata, E. & Otsuki, Y. (2008) Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model. Cancer Gene Ther. 15, 776-786.
29. Shirata, K., Suzuki, T., Yanaihara, N., Sugimoto, K. & Mori, K.J. (1991) Establishment of a sarcoma cell line, MS-K, expressing Ki-ras proto-oncogene product from mouse bone marrow stromal cells. Biomed. Pharmacother. 45, 1-8.
30. Sullivan, L.A. & Brekken, R.A. (2010) The VEGF family in cancer and antibody-based strategies for their inhibition. MAbs 2, 165-175.
31. Toda, K., Tsujioka, K., Maruguchi, Y., Ishii, K., Miyachi, Y., Kuribayashi, K. & Imamura, S. (1990) Establishment and characterization of a tumorigenic murine vascular endothelial cell line (F-2). Cancer Res. 50, 5526-5530.
32. Vaupel, P., Kallinowski, F. & Okunieff, P. (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 49, 6449-6465.
33. Wan, J., Chai, H., Yu, Z., Ge, W., Kang, N., Xia, W. & Che, Y. (2011) HIF-1alpha effects on angiogenic potential in human small cell lung carcinoma. J. Exp. Clin. Cancer Res. 30, 77.
34. Watanabe, M., Boyer, J.L. & Crystal, R.G. (2010) AAVrh. 10-mediated genetic delivery of bevacizumab to the pleura to provide local anti-VEGF to suppress growth of metastatic lung tumors. Gene Ther. 17, 1042-1051.
35. Wyckoff, J.B., Wang, Y., Lin, E.Y., Li, J.F., Goswami, S., Stanley, E.R., Segall, J.E., Pollard, J.W. & Condeelis, J. (2007) Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 67, 2649-2656.
36. Xu, H., Toyota, N., Xing, Y., Fujita, Y., Huang, Z., Touma, M., Wu, Q. & Sugimoto, K. (in press) Enhancement of phagocytosis and cytotoxicity in macrophages by tumor-derived IL-18 stimulation. BMB Rep.
37. Yan, J., Li, F., Ingram, D.A. & Quilliam, L.A. (2008) Rap1a is a key regulator of fibroblast growth factor 2-induced angiogenesis and together with Rap1b controls human endothelial cell functions. Mol. Cell. Biol. 28, 5803-5810.
38. Zhong, X.Y., Yoshioka, A., Mashio, Y., Ikeda, T., Jiang, H., Touma, M., Wu, Q., Wang, C. & Sugimoto, K. (2011) Effect of vegf gene knockdown on growth of the murine sarcoma cell line MS-K. Genes Cells 16, 625-638.